![Jonathan Clark Neal](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan Clark Neal
Director/Miembro de la Junta en Shire Pharmaceutical Contracts Ltd. .
Cargos activos de Jonathan Clark Neal
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Shire Pharmaceutical Contracts Ltd.
![]() Shire Pharmaceutical Contracts Ltd. Pharmaceuticals: MajorHealth Technology Shire Pharmaceutical Contracts Ltd. develops medicines for patients with rare diseases. The company was incorporated on June 2, 1986 and is headquartered in London, the United Kingdom. | Director/Miembro de la Junta | 12/03/2019 | - |
Shire Pharmaceuticals Ltd.
![]() Shire Pharmaceuticals Ltd. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov. | Director/Miembro de la Junta | 12/03/2019 | - |
Baxalta UK Ltd.
![]() Baxalta UK Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2014, Baxalta UK Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. that manufactures biopharmaceutical products. The company is based in London, UK. | Director/Miembro de la Junta | 12/03/2019 | - |
Auralis Ltd.
![]() Auralis Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Auralis Ltd. is a British company that develops and manufactures pharmaceutical products. The company is based in London, UK. The company was founded in 2005 by Simon Peter Bryson. Auralis was acquired by Shire ViroPharma, Inc., part of Takeda Pharmaceutical Co., Ltd. from January 27, 2014 on May 28, 2010 for $28.95 million. | Director/Miembro de la Junta | 12/03/2019 | - |
Historial de carrera de Jonathan Clark Neal
Estadísticas
Internacional
Reino Unido | 5 |
Operativa
Director/Board Member | 4 |
Sectorial
Health Technology | 5 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Shire Pharmaceutical Contracts Ltd.
![]() Shire Pharmaceutical Contracts Ltd. Pharmaceuticals: MajorHealth Technology Shire Pharmaceutical Contracts Ltd. develops medicines for patients with rare diseases. The company was incorporated on June 2, 1986 and is headquartered in London, the United Kingdom. | Health Technology |
Shire Pharmaceuticals Ltd.
![]() Shire Pharmaceuticals Ltd. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov. | Health Technology |
Baxalta UK Ltd.
![]() Baxalta UK Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2014, Baxalta UK Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. that manufactures biopharmaceutical products. The company is based in London, UK. | Health Technology |
Auralis Ltd.
![]() Auralis Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Auralis Ltd. is a British company that develops and manufactures pharmaceutical products. The company is based in London, UK. The company was founded in 2005 by Simon Peter Bryson. Auralis was acquired by Shire ViroPharma, Inc., part of Takeda Pharmaceutical Co., Ltd. from January 27, 2014 on May 28, 2010 for $28.95 million. | Health Technology |
- Bolsa de valores
- Insiders
- Jonathan Clark Neal
- Experiencia